Medizinische Universität Graz - Research portal
Reinisch Andreas |
Presentations at scientific and public conferences
Alihodžić, D; Özkaya, E; Foßelteder, J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler, A; Vujić, N; Kratky, D; Reinisch, A
Investigating the contribution of TET2 mutant human clonal hematopoiesis to human atherosclerotic plaque formation in a novel LDLR/ApoE double knock-out mouse model.
Doctoral Day 2024; 08.02.2024; Graz, AUSTRIA. 2024.
[Poster]
Alihodžić, D; Özkaya, E; Foßelteder J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler A; Vujić, N; Kratky, D; Reinisch A
CRISPR/Cas9 genome engineering to model TET2 mutant human clonal hematopoiesis and its pro-atherogenic potential.
Austrian Atherosclerosis Society (AAS) Annual Meeting; MAI 2-4, 2024; St. Gilgen, AUSTRIA. 2024.
[Poster]
ALIHODŽIĆ, D; ÖZKAYA1, E; PABST, G; FOßELTEDER, J; SCONOCCHIA, T; AUINGER, L; SCHLENKE, P; SILL1, H; ZEBISCH, A; WÖLFLER, A; REINISCH, A
Modeling SRSF2/TET2 mutational cooperativity in CMML development
European Hematology Association (EHA) 2024 Hybrid Congress; JUNE 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Balihodzic, A; Jäger, V; Reinisch, A; Jost, PJ; Strasser, A; Dengler MA
BCL-XL plays a role in determining lung cancer cell fate upon chemotherapy
Doctoral Day of Medical University of Graz; FEB 8, 2024; Graz. 2024.
[Oral Communication]
Dutta, S; Rezania, S; Lyssy, F; Lind, K; Vosberg, S; Thallinger, G; Zebisch, A; Wölfler, A; Pabst, G; Foßelteder, J; Reinisch, A; Sill, H;
Deciphering the molecular mechanism of mesenchymal stromal cell mediated drug resistance in acute myeloid leukemia.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Foßelteder, J; Brauchart, T; Schlacher, A; Sconocchia, T; Özkaya, E; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Reinisch, A;
Engineered cytokine-expressing mesenchymal stromal cells support ex vivo culture of human HSPCs and AML cells.
BMS Future Talks; SEP 27-28, 2024; Vienna, AUSTRIA. 2024.
[Poster]
Foßelteder, J; Özkaya, E; Alihodžić, D; Raicht, A; Reinisch, A;
Genome Engineering to model human clonal hematopoiesis and myeloid leukemogenesis.
Experimental and Translational Hematology Meeting 2024; OCT 11-12, 2024; Krakow, POLAND. 2024.
[Oral Communication]
Foßelteder, J; Özkaya, E; Dorset, SR; Bak, RO; Reinisch, A;
DNA base editing to model hot spot mutations and reconstruct myeloid disease development.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN;. 2024.
[Poster]
FullText
Lind, K; Dutta, S; Foßelteder, J; Pabst, G; Reinisch, A; Wölfler, A; Zebisch, A; Sill, H;
Deciphering early steps of TP53 aberrant human leukemogenesis.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Özkaya, E; Sconocchia, T; Foßelteder, J; Alihodzic, D;
Schlacher, A; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Reinisch, A
Genome engineered TET2 loss-of-function mutations increase stem cell self-renewal in human hematopoietic stem and progenitor cells.
Doctoral Day (DocDay); FEB 08 2024; Graz, Austria. 2024.
[Poster]
Ujcic, K; Forstner, D; Lyssy, F; Kupper, N; Brugger, B; Neuper, L; Daxboeck, C; Krappinger, J; Wernitznig, S; Feichtinger, J; Reinisch, A; Markert, U; Gauster, M
EFFECTS OF PLACENTA-DERIVED FACTORS ON MATERNAL MEGAKARYOCYTES AND THROMBOPOIESIS
PLACENTA. 2024; 154: E56-E56.-International Federation of Placenta Associations (IFPA); SEP 2-6, 2024; Montreal, CANADA.
[Poster]
Web of Science
Ujcic, K; Lyssy, F; Forstner, D; Kupper, N; Brugger, B; Wernitznig, S; Krappinger, J; Neuper, L; Daxboeck C; Hiden, U; Feichtinger, J; Kargl, J; Reinisch, A; Markert U; Gauster M
Effects of Placenta Derived Factors on Maternal Thrombopoiesis
Doctoral Day; FEB 8, 2024; Graz, AUSTRIA. 2024.
[Poster]
Ujčič, K; Neuper, L; Forstner, D; Lyssy, F; Kupper, N; Krappinger, J; Missbrenner, C; Brugger, B; Daxboeck, C; Wernitznig, S; Obermayer-Pietsch, B; Kargl, J; Feichtinger, J; Reinisch, A; Markert, UR; Gauster, M
Modulation of Thrombopoiesis by Placenta-Derived Factors: Insights from MEG-01 Cells.
https://www.faf.cuni.cz/Special/EPGC/Program/EPG-Conference2024-Program-Book-I.aspx. 2024; -19th European Placenta Group Conference 2024; NOV 7-8, 2024; Hradec Kralove, CZECH REPUBLIC.
[Poster]
Avdili, A; Auer, M; Bernecker, C; Brislinger, D; Reinisch, A; Schlenke, P; Dorn, I.
Molecular characterization of emerging hematopoiesis from human iPSCs
DocDay 2023; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Balihodzic, A; Fernandez-Hernandez, FJ; Jäger, V; Vosberg, S; Tonietto, M; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Doctoral Day of Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Galhuber, M; Michenthaler, H; Foßelteder J; Dutta, S; Reinisch, A; Krtic, J; Prokesch, A
Trp53 hotspot mutants’ response to HCC combination therapy
EMBO Workshop "Systems approaches in cancer"; JUN 26-30, 2023; Split, CROATIA. 2023.
[Poster]
Lyssy, F; Lind, K; Zöscher, F; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H; Dutta, S
Modelling drug resistance conferred by mono- and bi-allelic TP53 aberrations using isogenic AML cell lines
ONCOL RES TREAT. 2023; 46: 188-189.
[Poster]
Web of Science
FullText
Avdili, A; Auer, M; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I
GENERATION OF A CD43 FLUORESCENT REPORTER IPSC LINE TO TRACK HEMATOPOIETIC DEVELOPMENT
EXP HEMATOL. 2022; 111: S58-S58.
[Poster]
Web of Science
FullText
Avdili, A; Bernecker, C; Frisch, MT; Reinisch, A; Schlenke, P; Dorn, I.
Generation of a CD43 fluorescent reporter iPSC line to track hematopoietic development
24TH MEETING OF THE EUROPEAN RED CELL SOCIETY; April 7-11, 2022; Gazzado Schianno, Italy. 2022.
[Poster]
Avdili1, A; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I.
CRISPR/Cas9 mediated gene editing of human iPSC to track haematopoietic development
Sy-Stem Meeting 2022; APRIL 23-25, 2022; Vienna, Austria. 2022.
[Poster]
Dutta,S; Moritz,J; Pregartner,G; Thallinger,G; Brandstätter, I; Lind,K; Rezania,S; Lyssy,F; Reinisch,A; Zebisch,A; Berghold,A;Wölfler, A and Sill, H
AML and MDS patients with TP53 aberrations – a single cancer center experience.
Magazine of European Medical Oncology“. 2022; -Frühjahrestagung ÖGHO 2022; APR 8-10 2022; Graz, Austria.
[Oral Communication]
Fan, A; Azizi, A; Nuno, K; Nakauchi, Y; Zhao, FF; Cruz-Hernandez, D; Reinisch, A; Majeti, R
IL-3 SELECTIVELY RESCUES RUNX1-DEFICIENT HUMAN HSPCS WITH DYSREGULATED JAK/ STAT SIGNALING
EXP HEMATOL. 2022; 111: S84-S84.
[Poster]
Web of Science
Pabst, G; Foßelteder, F; Schlacher, A; Auinger, L; Martinez-Krams, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, Ch; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A;
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells.
Blood (2021) 138 (Supplement 1): 2160.. 2022; 138: 2160-2160.-ASH Annual Meeting 2021; DEZ 11-14, 2021; Atlanta, USA.
[Poster]
FullText
Schmitt, L; Bainschab, A; Beham-Schmid, C; Reinisch, A; Zitta, S; Wölfler, A
Renal function in patients with BCR-ABL-negative myeloproliferative neoplasms
OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA. 2022.
[Poster]
Telebar, F; Berg, JL; Perfler, B; Bramreiter, B; Caraffini, V; Prokesch, A; Geissler, K; Penz, T; Schuster, M; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A;
Co-occurrence of mutations modifying RAS and EZH2 inactivation in chronic myelomonocytic leukemia causes amplification of RAS-AKT signaling and increases the sensitivity to AKT inhibitors
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15 (Suppl 3), 37–67 (2022). . 2022; 15( ):S65--OeGHO- & AHOP-Frühjahrstagung 2022; April 8-10, 2022; Graz, Austria.
[Oral Communication]
FullText
Berg, JL; Perfer, B; Hatzl, S; Reinisch, A; Pregartner, G; Klymiuk, I; Tierling, S; Geissler, G; Strobl, H; Berghold, A; Wölfer, A; Sill, H; Zebisch, A
Aberrant expression of micro-RNA-125a plays a role in the pathogenesis and treatment of chronic myelomonocytic leukemia – Update
memo - Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2021; 14: -Annual Meeting of the Austrian Society
of Haematology and Medical Oncology; APR 8-10, 2021; Wien.
[Poster]
Foßelteder, J; Rosenberger, A; Pabst, G; Sill, H; Wölfler, A; Reinisch, A
Calreticulin mutations transform healthy hematopoietic stem cells into myeloproliferative neoplasms.
Doctoral Day 2021 at Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Foßelteder, J; Schlacher, A; Pabst, G; Amtmann, B; Schöll, W; Kashofer, K; Beham-Schmid, C; Schlenke, P; Greinix, HT; Sill, H; Woelfler, A; Zebisch, A; Reinisch, A
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-147919
[Poster]
Web of Science
FullText
FullText_MUG
Pabst, G; Foßelteder, J; Schlacher, A; Auinger, L; Martinez-Krams3, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, C; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-149591
[Poster]
Web of Science
FullText
FullText_MUG
Tvorogov, D; Thompson-Peach, CAL; Fosselteder, J; Dottore, M; Stomski, F; Lim, KSY; Onnesha, SA; Ross, DM; Reinisch, A; Thomas, D; Lopez, AF
A Calreticulin Neoepitope-Directed Monoclonal Antibody Can Overcome JAK Inhibitor Resistance and Block TPO-Independent Megakaryocyte Differentation
BLOOD. 2021; 138:
Doi: 10.1182/blood-2021-154332
[Poster]
Web of Science
FullText
FullText_MUG
Fan, A; Azizi, A; Nuno, K; Nakauchi, Y; Zhao, F; Reinisch, A; Cruz Hernandez, D; Majeti, R;
Cytokine Rescue and Targeting of Inflammation-Sensitive RUNX1 Deficient Human CD34 + Hematopoietic Stem and Progenitor Cells.
Blood (2020) 136 (Supplement 1): 14–15.. 2020; 136: 14-15.-ASH Annual Meeting 2020; DEZ 5-8, 2020; virtuell.
[Oral Communication]
FullText
Avdili, A; Bernecker, C; Frisch, MT, Reinisch, A; Schlenke, P; Dorn, I.
Generation of a CD43 fluorescent reporter cell line using CRISPR/Cas9 gene editing to track hematopoietic development from human iPSCs
8th annual GSCN Conference; SEPT 23-25, 2020; Ulm, Germany. 2020.
[Poster]
FullText
Koehnke, T; Sharma, R; Nakauchi, Y; Reinisch, A; Majeti, R;
Induction of Truncating ASXL1 Mutations in Human CD34+ HSPCs Mimics Human ASXL1-Mutated Clonal Hematopoiesis and Progression to Myeloid Malignancies.
Blood (2019) 134 (Supplement_1): 820.. 2019; 134: 820-820.-ASH Annual Meeting 2019; DEZ 7-10, 2019; Orlando, USA.
[Oral Communication]
FullText
Auinger, L; Rupp, V; Foßelteder, J; Frömmel, M; Geigl, J; Reinisch, A; Heitzer, E; Speicher, M;
Genetic Modelling of the BAP1 Tumour Predisposition Syndrome in Human iPSCs using an Inducible Knock-Out System
International Student Congress; MAI 31-JUNI 1, 2019; Medizinische Universität Graz. 2019.
[Poster]
FullText
Auinger, L; Rupp, V; Foßelteder, J; Reinisch, A; Geigl, J; Heitzer, E; Speicher, M;
How to Knock Out a Gene - the hard way
DocDay; NOV 21, 2019; Medizinische Universität Graz. 2019.
[Poster]
FullText
Berg, JL; Perfler, B; Hatzl, S; Reinisch, A; Geissler, K; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Expression of miR-125a is decreased in chronic myelomonocytic leukemia and of relevance for the treatment with 5-azacytidine
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology, Magazine of European Medical Oncology. 2019; 12: 53--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Foßelteder, J; Wölfler, A; Kargl, J; Schöll, W; Schlenke, P; Sill, H; Reinisch, A
In-vitro modeling of JAK2 V617F-driven myeloproliferative neoplasms
using CRISPR/Cas9 genome engineering.
DocDay 2019, Medical University of Graz; 21.11.2019; Graz, AUSTRIA. 2019.
[Poster]
Gornicec, M; Reinisch, A; Hatzl, S; Schilcher, G; Wölfler, A; Schulz, E
Sustained complete remission with Ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis: a case report
Oncol Res Treat 2019;42(suppl 4):1-336. 2019; -Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2019; Berlin, GERMANY.
[Poster]
FullText
Mosinzer, S; Foßelteder, J; Avdili, A; Schlenke, P; Reinisch, A
Generation of a TP53 isogenic cell line using CRISPR/Cas9 genome engineering
DocDay 2019, Medical University of Graz; Nov 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
Daga, S; Rosenberger, A; Krisper, N; Prietl, B; Reinisch, A; Zebisch, A; Sill, H; Wolfler, A
GPR56 and CLL-1 (CLEC12A) as putative leukemic stem cell markers in CD34-positive acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 73-73.
[Poster]
Web of Science
Daga, S; Rosenberger, A; Krisper, N; Reinisch, A; Zebisch, A; Sill, H; Wölfler, A
GPR56 is a putative marker of leukemic stem cells in CD34-positive acute myeloid leukemia.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2018; Supplement 1/18: -Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA.
[Poster]
Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wolfler, A; Sill, H; Zebisch, A
Deregulation of the micro-RNA-23a/TOP2B axis causes resistance to cytarabine in acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 243-243.
[Oral Communication]
Web of Science
Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
Increased expression of micro-RNA-23a causes resistance to cytarabine in acute myeloid leukemia.
Proceedings of the Annual Meeting of the
Austrian Society of Haematology and Medical Oncology
. 2018; Supplement 1/18: 26-26.-Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA.
[Oral Communication]
Nakauchi, Y; Thomas, D; Sharma, R; Corces, MR; Reinisch, A; Cruz, D; Koehnke, T; Karigane, D; Fan, A; Majeti, R;
Azacitidine and Ascorbate Inhibit the Competitive Outgrowth of Human TET2 Mutant HSPCs in a Xenograft Model of Pre-Leukemia.
Blood (2018) 132 (Supplement 1): 887.. 2018; 132: 887-887.-ASH Annual Meeting 2018; DEZ 1-4, 2018; San Diego, USA.
[Oral Communication]
FullText
Kinzer, M; Hingerl, K; König, J; Reinisch, A; Huppertz, B; Strunk, D; Dohr, G; Lang, I (2013)
Mesenchymale Stromazellen der humanen Plazenta verbessern die Neovaskulariserung im Mausmodell in vivo.
Journal für Reproduktionsmedizin und Endokrinologie. 2013; -Gemeinsame Jahrestagung OEGRM (Österreichische Gesellschaft für Reproduktionsmedizin und Embryologie), Österreichische IVF Gesellschaft; SEPT 26-28; Innsbruck, AUSTRIA.
[Oral Communication]
Kinzer, M; Hingerl, K; Reinisch, A; Strunk, D; Huppertz, B; Lang, I
Mesenchymal stromal cells from the human placenta induce pro-angiogenic effects in a mouse model in vivo
Erster Internationaler Studierenden Kongress (ISC); JUL 4-6, 2013; Graz, AUSTRIA. 2013.
[Oral Communication]
Diwoky, C; Gungl, D; Reinisch, A; Hofmann, NA; Strunk, D; Stollberger, R
Robust In-Vivo Detection of SPIO Lebeled Cells with MRI.
BioNanoMed; MAR 1-2, 2012; Krems, AUSTRIA. 2012.
[Poster]
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Hofmann, N; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
Platelet-derived factors preserve human mesenchymal cell stemness and promote endochondral bone and marrow niche formation via PDGF-receptor signalling
BONE MARROW TRANSPL. 2012; 47: S49-S50.
[Oral Communication]
Web of Science
Hofmann, N; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirth, M; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D
Neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells.
Magazine of European medical oncology Suppl 01/12. 2012; 2-3.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2007; Graz, Austria.
[Keynote lecture]
Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Fruewirth, M; Beham-Schmid, C; Linkesch, W; Andreef, M; Strunk, D
Novel role of oxygen sensing mesenchymal stem/progenitor cells as initiators of neo-vasculogenesis in vivo.
Haematologica. 2012; 1 (2012)(97(s1)):481-482.-17th Congress of EHA; JUN 14-17, 2012; Amsterdam, NETHERLANDS.
[Oral Communication]
Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirt, M; Liechtenstein, N; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D
A Novel Role for Mesenchymal Stem / Progenitor Cells As Hypoxia Sensors During Initiation of Neo-Vasculogenesis in Vivo.
Blood. 2012; 120(21):613-613.-54th ASH Annual Meeting and Exposition; DEC 8-11, 2012; San Diego, USA.
[Keynote lecture]
Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirth, M; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D
Neo-Vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells.
2012 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology.. 2012; 5(1):2-3.-ÖGHO; APR 12-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Etchart, N; Schallmoser, K; Fruehwirth, M; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
Therapeutic neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem/progenitor cells
BONE MARROW TRANSPL. 2012; 47: S319-S320.
[Poster]
Web of Science
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Frühwirth, M; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
Oxygen Sensing Mesenchymal Stem and Progenitor Cells Initiate Neo-Vasculogenesis in vivo.
45. Jahrestagung der DGTI. 2012; 39(suppl1):17-17.-DGTI; SEP 11-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Reinisch, A
Engineering a humanized stem cell niche to study normal and malignant hematopoiesis.
ÖGHO; APR 12-14, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Reinisch, A
Endotheliale kolonie-bildenende Progenitorzellen: Identifikation, Isolierung, Expansion und potentieller klinischer Einsatz für Regenerative Zelltherapie.
IGLD; MAR 15-17, 2012; Essen, GERMANY. 2012.
[Oral Communication]
Reinisch, A
Epigenetische Faktoren beeinflussen die klinische Anwendbarkeit
von MSC.
45. Jahreskongress der Deutschen DGTI Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI). 2012; 39(suppl1):17-17.-DGTI; SEP 11-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Reinisch, A
Entwicklung einer humanisierten Knochenmarksnische zur Analyse humaner Blutbildung in der Maus.
Flow Time; SEP 20-21, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Reinisch, A
Thrombozytenlysate versus Tierseren: HPL versus FBS: Influence on Cell Function.
IGLD; MAR 15-17, 2012; Essen, GERMANY. 2012.
[Oral Communication]
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Ortner, A; Thaler, D; Feilhauer, B; Hartwig, UF; Beham-Schmid, C; Trajanosky, S; Wagner, W; Alves, F; Schallmoser, K; Andreeff, M; Strunk, D;
Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo.
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
Doi: 10.1182/blood.V120.21.2987.2987
[Poster]
Web of Science
FullText
FullText_MUG
Reinisch, A; Etchart, N; Hofmann, NA; Frühwirth, M; Ortner, A; Url, C; Rohban, R; Schallmoser, K; Beham-Schmid, C; Strunk D
Platelet-Derived Factors Maintain Human Mesenchymal Stem and Progenitor Cell Potency in vivo.
45. Jahrestagung der DGTI. 2012; 39(suppl1):1-1.-DGTI; SEP 11-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Thaler, D; Feilhauer, B; Ortner, A; Beham-Schmid, C; Trajanoski, S; Wagner, W; Schallmoser, K; Strunk, D
Bone and haematopoietic niche formation is predetermined by a specific epigenetic signature
BONE MARROW TRANSPL. 2012; 47: S48-S49.
[Oral Communication]
Web of Science
Rohban, R; Etchart, N; Reinisch, A; Hofmann, N; Thaler, D; Feilhauer, B; Dacheva, M; Schallmoser, K; Rohde, E; Strunk, D
Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis
BONE MARROW TRANSPL. 2012; 47: S49-S49.
[Oral Communication]
Web of Science
Rohban, R; Etchart, N; Reinisch, A; Hofmann, NA; Schallmoser, K; Ortner, A; Rohde, E; Strunk, D
Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis.
2012 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology.. 2012; 5(1):4-4.-ÖGHO; APR 12-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Rohban, R; Etchart, N; Reinisch, A; Url, C; Schallmoser, K; Hofmann, NA; Ortner, A; Feilhauer, B; Thaler, D; Rohde, E; Strunk, D
Early in vivo Signaling Signature During Human Stem/Progenitor Cell-Derived Neo-Vasculogenesis.
45. Jahrestagung der DGTI. 2012; 39(suppl1):2-2.-DGTI; SEP 11-14, 2012; Graz, AUSTRIA.
[Oral Communication]
Schallmoser, K; Hofmann, NA; Reinisch, A; Ortner, A; Url, C; Etchart, N; Joussen, S; Wagner, W; Strunk, D;
Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions.
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
Doi: 10.1182/blood.V120.21.1916.1916
[Poster]
Web of Science
FullText
FullText_MUG
Schallmoser, K; Ortner, A; Hofmann, NA; Etchart, N; Joussen, S; Url, C; Wagner, W; Strunk, D
Enhanced MSPC Proliferation without Senescence Aggravation in an Elevated Oxygen Environment.
45. Jahrestagung der DGTI. 2012; 39(suppl1):32-33.-DGTI; SEP 11-14, 2012; Graz, AUSTRIA.
[Poster]
Etchart, N; Reinisch, A; Gungl, D; Hofmann, NA; Rohban, R; Ortner, A; Rankl, J; Hofmeister, A; Beham-Schmid, C; Schallmoser, K; Strunk, D
Human platelet-derived factors maintain a bone and marrow niche-competent function of mesenchymal stem/progenitor cells
BONE MARROW TRANSPLANT. 2011; 46: S303-S303.
[Poster]
Web of Science
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
Platelet-Derived Factors Allow Human Mesenchymal Stem Cells to Spontaneously Undergo Endochondral Bone Differentiation and Provide Bone Marrow Support in a Xenogenic In Vivo Model
BLOOD. 2011; 118(21): 583-584.
[Poster]
Web of Science
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Fruewirth, M; Diwoky, C; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
Neo-Vasculogenesis In Vivo Is Facilitated by Oxygen Sensing Mesenchymal Stem and Pogenitor Cells
BLOOD. 2011; 118(21): 319-319.
[Oral Communication]
Web of Science
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Frühwirth, M; Beham-Schmid, C; Andreef, M; Strunk, D
Oxygen sensing of mesenchymal stem and progenitor cells promotes neo-vasculogenesis in vivo.
European Surgery: 25th Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics. 2011; 43(242):23-23.-Austrotransplant; OCT 19-22, 2011; Graz, AUSTRIA.
[Oral Communication]
Hofmann, NA; Reinisch, A; Ortner, A; Etchart, N; Schallmoser, K; Absenger, M; Strunk, D
Vascular regeneration in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells
BONE MARROW TRANSPLANT. 2011; 46: S302-S302.
[Poster]
Web of Science
Reinisch, A
Molecular Imaging of Human Stem Cells.
Nanonet Day 2011; FEB 14, 2011; Graz, AUSTRIA. 2011.
[Oral Communication]
Reinisch, A; Etchart, N; Hofmann, NA; Gungl, D; Ortner, A; Rankl, J; Beham-Schmid, C; Schallmoser, K; Strunk, D
Unexpected somatic restriction of mesenchymal stem and progenitor cells after transplantation in vivo
BONE MARROW TRANSPLANT. 2011; 46: S302-S303.
[Poster]
Web of Science
Reinisch, A; Liechtenstein, N; Hofmann, NA; Ortner, A; Frühwirth, M; Schallmoser, K; Beham-Schmid, C; Strunk, D
Tissue Specific epigenetic memory: differentiation capacity of mesenchymal stem cell is restricted to their tissue of origin.
European Surgery: 25th Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.. 2011; 43(242):7-7.-Austrotransplant; OCT 19-22, 2011; Graz, AUSTRIA.
[Poster]
Reinsch, A; Liechtenstein, N; Hofmann, NA; Ortner, A; Fruhwirth, M; Schallmoser, K; Beham-Schmid, C; Strunk, D
Dissociation of In Vivo and in Vitro Differentiation Capacity of Human Mesenchymal Stem Cells Is Reflected by a Tissue Specific Epigenetic Memory
BLOOD. 2011; 118(21): 1027-1028.
[Poster]
Web of Science
Rohban, R; Reinisch, A; Hofmann, NA; Url, C; Liechtenstein, N; Rohde, E; Schallmoser, K; Strunk, D
Early in vivo signalling events involved in neo-vasculogenesis via stem cell transplantation using proteomic profiling.
European Surgery: 25th Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.. 2011; 43(242):23-23.-Austrotransplant; OCT 19-22, 2011; Graz, AUSTRIA.
[Oral Communication]
Rohban, R; Reinisch, A; Rohde, E; Hofmann, NA; Gimona, M; Etchart, N; Ortner, A; Strunk, D
Identification of early in vivo signalling signature during regenerative stem cell therapy using proteomic profiling
BONE MARROW TRANSPLANT. 2011; 46: S50-S50.
[Oral Communication]
Web of Science
Etchart-Liechtenstein, N; Reinisch, A; Gungl, D; Hofmann, NA; Rohban, R; Rankl, J; Url, C; Hofmeister, A; Schallmoser, K; Rohde, E; Strunk, D
Predicting the bone-regenerating potential of MSPCs from various histological origins: strong discrepancy between osteogenic differentiation in vitro and bone formation in vivo.
ZMF & Doctoral Day; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Oral Communication]
Hofmann, N; Reinisch, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
HYPOXIA MAINTAINS STEMNESS OF ENDOTHELIAL PROGENITOR CELLS.
HAEMATOL-HEMATOL J. 15th Congress of the European Hematology Association.. 2010; 95(s2):0246-109.-15th Congress of the European Hematology Association.; JUN 10-13, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser K; Rohde, E; Absenger, M; Birner-Gruenenberger, R; Strunk, D
Oxygen sensing regulates somatic endothelial progenitor cell function.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):12-12.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA.
[Oral Communication]
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo.
BLOOD. 2010; 116(21):1750-1750.
[Oral Communication]
Web of Science
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Grünberger, R; Strunk, D
Oxygen sensing of mesenchymal stem and progenitor cells promotes neo-vasculogenesis in vivo.
ZMF & Doctoral Day; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Poster]
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Grünberger, R; Strunk, D
Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo.
52nd Annual Meeting of the American Society of Hematology.. 2010; 116(21):1750-1750.-American Society of Hematology; DEC 4-7, 2010; Orlando, USA.
[Oral Communication]
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Absenger, M; Birner-Gruenberger, R; Strunk, D
Hypoxia maintains stemness of somatic endothelial colony forming progenitor cells
BONE MARROW TRANSPLANT. 2010; 45: S279-S279.
[Poster]
Web of Science
Ortner, A; Reinisch, A; Etchart-Liechtenstein, N; Strunk, D
Epigenetic Modification of Human Stem Cells.
ZMF & Doctoral Day; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Oral Communication]
Reinisch, A
Towards a Better Understanding of Non-Hematopoietic Stem and Progenitor Cell Biology and Function.
Annual Meeting of the Austrian Society for Reproductive Medicine and Endocrinology. ; OCT 16, 2010; Krems a.d. Donau, AUSTRIA. 2010.
[Oral Communication]
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeiser, A; Stollberger, R; Alves, F; Strunk, D
Vascular progenitor cells can instruct developmental fate decision of mesenchymal stem and progenitor cells.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):12-13.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA.
[Oral Communication]
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo.
BLOOD. 2010; 116(21):414-415.
[Oral Communication]
Web of Science
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo.
52nd Annual Meeting2010; 116(21):414-415.-American Society of Hematology; DEC 4-7, 2010; Orlando, USA.
[Oral Communication]
Web of Science
Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
HAEMATOL-HEMATOL J. 15th Congress of the European Hematology Association. 2010; 95(s2):0509-220.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN.
[Oral Communication]
Web of Science
Reinisch, A; Hofmann, N; Ortner, A; Etchart, N; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
VASCULAR PROGENITOR CELLS CAN INSTRUCT DEVELOPMENTAL FATE DECISION OF CD146(+) MESENCHYMAL STROMAL/STEM CELLS IN VIVO
HAEMATOL-HEMATOL J. 2010; 95: 1160
[Oral Communication]
Web of Science
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S52-S52. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Reinisch, A; Hofmann, NA; Ortner, A; Etchart, N; Beham-Schmidt, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
Vascular progenitor cells can instruct skeletal stem cells during developmental fate decisions
BONE MARROW TRANSPLANT. 2010; 45: S53-S53.
[Oral Communication]
Web of Science
Reinisch, A; Thaler, D; Feilhauer, B; Frühwirth, M; Etchart-Liechtenstein, N; Schallmoser, K; Rohde, E; Hofmann, NA; Hartwig, U; Strunk, D
Combined action of endothelial and mesenchymal niche cells to amplify hematopoietic progenitor expansion in a humanized system.
ZMF & Doctoral Day; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Poster]
Rohban, R; Reinisch, A; Hofmann, NA, Ortner, A; Url, C; Etchart-Liechtenstein, N; Birner-Gruenberger, R; Rohde, E; Strunk, D
Early in vivo signalling events between endothelial and mesenchymal progenitor cells during neovasculogenesis.
ZMF & Doctoral Day; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Poster]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
HAEMATOL-HEMATOL J. 2010; 95: 1059-
[Poster]
Web of Science
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Lanzer, G; Strunk, D
THERAPEUTIC ANGIOGENESIS WITH CELLULAR THERAPY: PRO-ANGIOGENIC INDUCTION OF MYELOID CELLS CAN FAVOR MAPK P38-DEPENDENT FOAM CELL DEVELOPMENT.
VOX SANG. XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI. 2010; 99(1):20-20.-XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI; JUN 26-JUL 2, 2010; Berlin, GERMANY.
[Poster]
Web of Science
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Froehlich, E; Strunk D
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis favors MAPK p38-dependent foam cell formation.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):13-13.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA.
[Oral Communication]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Fröhlich E; Strunk, D
Pro-Angiogenic Induction of Myeloid Cells for Therapeutic Angiogenesis Can Favor MAPK p38-dependent Foam Cell Formation.
52nd annual meeting2010; 116(21):1836-1836.-Annual Society of Hematology; DEC 4-7, 2010; Orlando, USA.
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D
MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
BONE MARROW TRANSPLANT. 2010; 45: S283-S283. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95(s2):0249-110.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
Replicative senescence-associated gene expression changes in mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S281-S281.
[Poster]
Web of Science
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
Replicative senescence induces gene expression changes in human MSCs.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):7-8.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA.
[Oral Communication]
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
Replicative Senescence-Associated Gene Expression Changes In Human MSPCs Independent of Genomic Variations.
52nd annual meeting2010; 116(21):1839-1839.-American Society of Hematology; DEC 4-7, 2010; Orlando, USA.
Schallmoser K; Bartmann, C; Rohde E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
Similarity of Replicative Senescence-Associated Gene Expression Changes in Mesenchymal Stromal Cells under Various Culture Conditions.
XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI2010; 99(1):481-482.-XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI; JUN 26-JUL 2, 2010; Berlin, GERMANY.
[Poster]
Web of Science
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
TRANSFUSION. 2010; 50: 24A-24A.-AABB; 08.-12.10.2010; Baltimore, MD, USA.
[Oral Communication]
Web of Science
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95: 0247
[Poster]
Web of Science
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch W; Strunk, D
Genomic Stability in Long-Term Cultured Mesenchymal Stromal/Stem Cells.
Genomic Stability in Long-Term Cultured Mesenchymal Stromal/Stem Cells. 2010; 2010(s2):109-109.-15th Congress of the European Hematology Association; JUN 10-13, 2010; Barcelona, SPAIN.
[Poster]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Alteration of genomic stability in long-term cultured mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S280-S280.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
Sourij, H; Hofmann, NA; Tripolt, N; Reinisch, A; Eder, M; Pieber, TR; Strunk, D
ENDOTHELIAL COLONY-FORMING CELL OUTGROWTH IS CORRELATED WITH INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN TYPE 2 DIABETIC PATIENTS
ATHEROSCLER SUPPL. 2010; 11(2): MS156
Doi: 10.1016/S1567-5688(10)70657-7
Web of Science
FullText
FullText_MUG
Sourij, H; Hofmann, NA; Tripolt, NJ; Reinisch, A; Eder, M; Pieber, TR; Strunk, D
Endothelial Colony-Forming Cell-Wachstum korreliert mit der Intima-media-Dicke und kardiovaskulären Risikofaktoren bei Patienten mit Typ-2-Diabetes
Austrian Journal of Endocinology and Metabolism2010; Sonderheft 1: 18-18.-15. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; 7.-8.Mai 2010; Wien. (ISBN: 1998-7773 )
[Poster]
Thaler, D; Feilhauer, B; Frühwirth, M; Schallmoser, K; Rohde, E; Hofmann, NA; Hartwig, U; Reinisch, A; Strunk, D
Combined action of endothelial and mesenchymal niche cells to amplify hematopoietic progenitor expansion in a humanized system.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):14-14.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA.
[Oral Communication]
Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D
Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
BONE MARROW TRANSPLANT. 2010; 45: S53-S53. - 36th Annual Meeting of hte European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system.
BONE MARROW TRANSPLANT. 2009; 43: S188-S189.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN.
[Poster]
Web of Science
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Absenger, M; Birner-Gruenberger, R; Strunk, D
Oxygen: A key regulator of somatic endothelial progenitor cell function.
Joint ZMF & Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. 2009.
[Poster]
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Birner-Gruenberger, R; Strunk, D
Oxygen Sensing of Somatic Endothelial Progenitor Cells
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology. 2009; 2(2):3-3.-ÖGHO Frühjahrestagung; APR 16-18; Salzburg, AUSTRIA. (ISBN: 1865-5041 )
[Oral Communication]
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Birner-Gruenberger, R; Strunk, D
Oxygen sensing as a key factor regulating somatic endothelial progenitor cell function.
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.2009; 41(231):32-32.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.; OCT 21-23, 2009; Seefeld, AUSTRIA.
[Poster]
Hofmann, N.A.; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Birner-Gruenenberger, R; Strunk, D
Oxygen-Dependent Regulation of Somatic Endothelial Progenitor Cell Function.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009.
[Poster]
Reinisch, A
Herstellung von ECFC (endothelial colony forming cells) aus peripherem Blut für die potentielle klinische Anwendung.
Interdisziplinäre Gruppe für Labordiagnostik und Durchflusszytometrie.; MAR 12-13, 2009; Munich, GERMANY. 2009.
[Oral Communication]
Reinisch, A
Stem Cell Tracking by Nanoparticle-Based Technologies.
Nanoscience Foundries and Fine Analysis Meeting; JUL 1-2, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S19-S20.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN.
[Oral Communication]
Web of Science
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
MESENCHYMAL STROMAL CELLS (MSC) SUPPORT VASCULAR REGENERATION BY ADULT BLOOD-DERIVED ENDOTHELIAL COLONY-FORMING CELLS (ECFC) EXPANDED UNDER ANIMAL SERUM-FREE CONDITIONS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009.
[Poster]
Reinisch, A; Hofmann, N.A.; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D
Humanized Large-Scale Animal Serum-Free Expanded Blood-Derived Endothelial Colony-Forming Cells Function In Vitro and In Vivo.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009.
[Poster]
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
Therapeutic Vasculogenesis in Vivo by Co-Transplantation f Endothelial and Mesenchymal Progenitor Cells.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):166-167.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 )
[Oral Communication]
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
Stable vascular regeneration through co-application of adult blood-derived endothelial colony-forming cells (ECFCs) and mesenchymal stromal cells (MSCs).
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.2009; 41(231):23-23.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.; OCT 21-23, 2009; Seefeld, AUSTRIA.
[Oral Communication]
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher; MR; Strunk, D
Making functional Endothelial progenitors: animal serum-free humanized large-scale propagated adult blood-derived Endothelial colony-forming cells assemble stable perfused vessel in vivo.
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):1-2.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 )
[Oral Communication]
Reinisch, A; Hofmann, NA; Ortner, A; Chatterjee, S; Dullin, C; Beham-Schmid, C; Alves, F; Strunk, D
Instructive role of vascular progenitor cells during developmental fate decision of skeletal stem cells.
Joint ZMF& Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. 2009.
[Poster]
Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
Pro-atherogenic risk of cellular therapy for vascular regeneration?
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S203-S204.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN.
[Poster]
Web of Science
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D
CELLULAR THERAPEUTIC ANGIOGENESIS: IN VITRO FOAM CELL DEVELOPMENT OF MONOCYTES BUT NOT MESENCHYMAL STROMAL CELLS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009.
[Poster]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D
In vitro Foam Cell Development of Bone Marrow-Derived Cells: Implications for Therapeutic Angiogenesis?
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):215-216.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 )
[Oral Communication]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D
Increased Foam Cell Potential of Human Blood and Marrow-Derived Cells after Pro-Angiogenic Induction as an Apparent Risk Factor of Therapeutic Angiogenesis.
42nd Annual Meeting of the German Society for Transfusion Medicine and Immunohematology2009; 26(S1):45-45.-German Society for Transfusion Medicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 )
[Poster]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D
Foam Cell Development of human Blood and Marrow-Derived Cells as a Risk Factor of Therapeutic Angiogenesis?
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009.
[Poster]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D
Safety of stem cell transplantation to treat cardiovascular diseases: foam cell formation of human blood and marrow-derived cells as a risk factor of therapeutic angiogenesis?
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):10-11.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA.
[Oral Communication]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA.; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D
Elevated Foam Cell Formation After Pro-Angiogenic Inductions of Human Blood and Marrow-Derived Cells as an Apparent Risk Factor of Therapeutic Angiogenesis.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009.
[Poster]
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D
Atherogenesis as a risk factor accompanying cellular therapeutic angiogenisis?
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):19-20.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 )
[Poster]
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer G; Linkesch, W; Strunk, D
Variations in Genomic Stability Revealed by Long-Term Cultured Human MSCs.
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009.
[Poster]
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Long-term cultured human MSCs reveal variations in genomic stability.
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):9-10.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA.
[Oral Communication]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system.
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S187-S187.-35th Annual Meeting of the European Group for Blood and MarrowTransplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN.
[Poster]
Web of Science
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann C; Lanzer, G; Linkesch, W; Strunk, D
Variations in Genomic Stability of Human Mesenchymal Stromal Cells Due to Long-Term Culture.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009.
[Poster]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Human MSC Expansion in an Animal Serum-free System: A GMP-Compliant Protocol for Safe and Genomically Stable MSCs.
2009 Proceedings of the Austrian Society of Heamatology and Oncology2009; 2(2):18-18.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 )
[Poster]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Genomic Variations in Human Mesenchymal Stromal Cells Induced by Long-Term Culture.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie.2009; 32(4):62-63.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 )
[Poster]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Long-Term Culture of Human MSCs Induces Variations in Genomic Stability.
42nd Annual Meeting of the German Society for Transfusion MEdicine and Immunohematology2009; 36(S1):22-22.-42nd Annual Meeting of the German Society for Transfusion MEdicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 )
[Oral Communication]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
ALTERED GENOMIC STABILITY DUE TO LONG-TERM CULTURE OF HUMAN MSCs.
3rd International Workshop on Multipotent Stomal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009.
[Poster]
Diwoky, C; Reinisch, A; Neumayer, B; Strunk, D; Stollberger, R
High Sensitivity Positive Contrast Imaging of Stem Cells in Bone Marrow.
2008 World Molecular Imaging Congress; SEP 10-13, 2008; Nice, FRANCE. 2008.
[Oral Communication]
Diwoky, C; Reinisch, A; Strunk, D; Stollberger, R.
MRI of Stem Cells in Bone Marrow.
ÖGMP Annual Meeting and 3rd AISCMP Meeting; MAY, 30-31, 2008; Graz, AUSTRIA. 2008.
Frühwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System.
Fiftieth annual meeting abstracts2008; 112(11):840-840.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA.
[Oral Communication]
Web of Science
Mayer, A; Rinner, B; Reinisch, A; Strohmaier, H; Fröhlich, E
Flow Cytometric assessment of pro-coagulating and inflammatory action of nanoparticles
XXIV International Congress International Society for Analytical Cytology (ISAC)2008; A144 P42: 149--XXIV International Congress International Society for Analytical Cytology (ISAC); MAY 17-21, 2008; Budapest, HUNGARY.
[Poster]
Reinisch, A
How to define endothelial progenitor cells
Placental Endothelium and Endothelial Progenitor Cells; SEP 15, 2008; Graz, AUSTRIA. 2008.
[Oral Communication]
Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells.
. 2008; 41(1): S128-S128.
[Poster]
Web of Science
Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D
Molecular Imaging of Bone Marrow Stromal Cells Abstract only
Bone Marrow Transplantation2008; 41(1):S432-S432.-34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT); MAR 30-APR 2, 2008; Florence, Italy.
[Poster]
Web of Science
Reinisch, A; Diwoky, C; Hofmann, NA; Schallmoser, K; Rohde, E; Ingolic, E; Linkesch, W; Stollberger, R; Strunk, D
Magnetic Resonance Imaging of Functional Human Endothelial Progenitor Cells.
2008 World Molecular Imaging Congress; SEP 10-13, 2008; Nice, FRANCE. 2008.
[Poster]
Reinisch, A; Diwoky, C; Hofmann, NA; Schallmoser, K; Rohde, E; Ingolic, E; Linkesch, W; Stollberger, R; Strunk, D
High Sensitivity and High Resolution Magnetic Resonance Imaging of Functional Endothelial Progenitor Cells.
ZMF Day; NOV 12, 2008; Graz, AUSTRIA. 2008.
[Poster]
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D
Humanized Large-Scale Propagation of Vessel-Forming Endothelial Progenitor Cells.
ZMF Day; NOV 12, 2008; Graz, AUSTRIA. 2008.
[Poster]
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D
Making Functional Endothelial Progenitors: Humanized Large-scale Animal Serum-free Propagated Adult Blood-derived Endothelial Colony-forming Cells Assemble Stable Perfused Vessels In vivo.
Fiftieth Annual Meeting Abstracts2008; 112(11):659-659.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA.
[Poster]
Web of Science
Reinisch, A; Hofmann, NA; Rohde; E; Schallmoser, K; Kashofer, K; Thalder, D; Obenauf, A; Lanzer, G; Linkesch, W; Strunk, D
Oligoclonal Large Scale Expansion of Functional Human Endothelial Progenitor Cells without Animal Serum
Onkologie2008; 31(S4):141-141.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 )
[Poster]
Reinisch, A; Strunk D
Robust and functional vascular networks engineered in vivo with human blood-derived endothelial progenitor cells and mesenchymal stromal cells
Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 10-14; Vienna, AUSTRIA. 2008.
[Oral Communication]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells.
. 2008; 41(1): S314-S314.
[Poster]
Web of Science
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk D
Genomic stability of MSCs after short term clinical scale propagation in animal serum-free medium.
Onkologie2008; 31(S4):127-127.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 )
[Poster]
Schallmoser, K; Rohde E; Reinisch A; Obenauf AC; Bartmann C; Lanzer G; Linkesch W; Strunk D
Short Term Clinical Scale MSC Propagation in Animal Serum-Free Medium: Minimum Requirements for Sufficient Transplants
Joint Annual Congress of the German Society for Transfusion Medicine and Immunohaematology (DGTI) and the Interdisciplinary European Society for Haemapheresis and Haeomotherapy (ESFH) in Cooperation with the Societe Francaise de Transfusion Sanguine (SFTS)2008; 35(1):87-87.-41st Congress of the German Society for Transfusion Medicine and Immunohematology; SEP 16-19, 2008; Düsseldorf, GERMANY. (ISBN: 978-3-8055-9013-6 )
[Poster]
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
Genomic stability and safety of MSCs after animal serum-free humanized clinical scale propagation.
Fiftieth annual meeting abstracts2008; 112(11):805-805.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA.
[Poster]
Web of Science
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA.
[Poster]
Web of Science
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Human platelet-derived factors regulate gene expression of mesenchymal stem cells
Abstract Book2007; 117-117.-14th International Symposium on Recent Advances in Stem Cell Transplantation; April 26-28, 2007; Heidelberg, Germany.
[Oral Communication]
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression profiling of human MSC
Wiener Medizinische Wochenschrift2007; 157(121):11-11.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien.
[Poster]
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression profiling of human multipotent mesenchymal stromal cells.
Abstract Book2007; 33-33.-2nd Symposium on Geneexpression & Microarray Technology; Oct 4-5 2007; ZMF, Graz, Austria.
[Oral Communication]
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression profiling of human multipotent mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2007; 39: S51-S51.
[Oral Communication]
Web of Science
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Clinical scale propagation of functional cord blood stem cells in a humanized system
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA.
[Poster]
Web of Science
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic; Lanzer, G; Linkesch, W; Strunk, D
Clinical scale propagation of functional cord blood MSC in a humanized system
Wiener Medizinische Wochenschrift2007; 157(121):26-26.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien.
[Poster]
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Human platelet lysate preserves in vitro potency of umbilical cord blood-derived MSC.
Onkologie2007; 30 (Suppl.3): 134-134.-Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OKT 5-9, 2007; Basel, Switzerland.
[Poster]
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Abstract Book2007; 37-37.-2nd Symposium on Geneexpression & Microarray Technology; Oct. 4th- 5th 2007; ZMF, Graz; Austria.
[Oral Communication]
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Human platelet lysate (HPL) preserves in vitro potency of umbilical cord blood-derived MSC.
European Surgery2007; 30 (Suppl. 218): 28[68]-28.-21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OKT 17-20, 2007; St Wolfgang, AUSTRIA.
[Poster]
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Human platelet lysate (HPL) derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells.
Abstract Book2007; 711-711.-2nd Meeting of the Center for Medical Research ; Nov 21, 2007; ZMF, Graz, Austria.
[Oral Communication]
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
BONE MARROW TRANSPLANT. 2007; 39: S132-S133.
[Poster]
Web of Science
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk, D
Clinical scale expansion of functional cord blood derived MSC in a humanized system.
Abstract Book2007; 118-118.-14th International Symposium on Recent Advances in Stem Cell Transplantation; April 26-28, 2007; Heidelberg, Germany.
[Oral Communication]
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W, Guelly, C; Strunk, D
Endotheliale Marker auf myeloischen Zellen: Molekulare Mimkry oder Transdifferenzierung?
Interdisziplinäre Gruppe für Labordiagnostik und Durchflusszytometrie, IGLD Symposium 2007; MAR 16-17, 2007; Günzburg, Deutschland. 2007.
[Oral Communication]
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic the morphology of endothelial progenitor colonies in vitro
HAEMATOL-HEMATOL J. 2007; 92: 315-315.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA.
[Poster]
Web of Science
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic CFU-EC
Abstract Book2007; 109-109.-14th International Symposium on Recent Advances in Stem Cell Transplantation
; April 26-28, 2007; Heidelberg, Germany.
[Oral Communication]
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
T cells and monocytes form CFU-hill in vitro
Onkologie2007; 30(S3):217-217.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 5-9, 2007; Basel, Switzerland.
[Poster]
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic CFU-EC: unravelling the nature of endothelial progenitor cells
Wiener Medizinische Wochenschrift2007; 157(121):27-27.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien.
[Poster]
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic endothelial progenitor colonies
TRANSFUSION. 2007; 47(3):69A-69A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA.
[Poster]
Web of Science
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic endothelial progenitor colonies
BONE MARROW TRANSPLANT. 2007; 39: S123-S123.
[Poster]
Web of Science
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D
Multipotent mesenchymal stromal cells: minimum requirements for fully humanised clinical scale expansion
Onkologie [P531]2007; 30(S3):134-134.-Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OCT 5-9; 2007; Basel, SWITZERLAND.
[Poster]
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D
Minimum Requirements for fully humanized clinical scale MSC propagation.
Abstract Book2007; 711-711.-2nd Meeting of the Center for Medical Research; Nov 21, 2007; ZMF Graz, Austria.
[Oral Communication]
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D
Minimum requirements for fully humanized clinical scale MSC propagation.
European Surgery2007; 39 (Suppl. 218): 29--21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OKT 17-20, 2007; St Wolfgang, AUSTRIA.
[Poster]
Schallmoser, K; Bartmann, C; Rohde, E; Hofmann, N; Reinisch, A; Strunk, D
Role of cytokines and growth factors in stem cell biology
Bio-Plex Workshop, ZMF; NOV 6, 2007; Graz, AUSTRIA. 2007.
[Oral Communication]
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Gülly, C; Lanzer, G; Linkesch, W; Strunk, D
Clinical scale expansion of MSC with human platelet lysate
Wiener Medizinische Wochenschrift2007; 157(121):28-29.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien.
[Poster]
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
HAEMATOL-HEMATOL J. 2007; 92: 317-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA.
[Poster]
Web of Science
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D
Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
BONE MARROW TRANSPLANT. 2007; 39: S110-S110.
[Poster]
Web of Science
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D
Clinical scale expansion of human MSC supported by human platelet lysate.
Abstract Book2007; 110-110.-14th International Symposium on Recent Advances in Stem Cell Transplantation; April 26-28, 2007; Heidelberg, Germany.
[Oral Communication]
Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
Animal serum-free clinical scale propagation of human MSC
TRANSFUSION. 2007; 47(3):28A-28A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA.
[Oral Communication]
Web of Science
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Human platelet-derived factors regulate mesenchymal stem cell gene expression.
BLOOD. 2006; 108(11): 142B-142B.
[Poster]
Web of Science
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression of human mesenchymal stem cells is regulated by platelet-derived factors (poster & abstract)
EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells; OKT 6-8, 2006; Mandelieu, France. 2006.
[Poster]
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression profiling of mesenchymal stem cells: human platelet-derived factors regulate multiple biological processes.
European Surgery 20062006; 38 (Suppl.211)(8):O18--20th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics 2006; OCT 18-21; Hof, Salzburg, Austria.
[Poster]
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression of human mesenchymal stem cells is regulated by human platelet-derived factors.
1st Meeting of the Center for Medical Research; OCT 24; Graz. 2006.
[Oral Communication]
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Gene expression profiling of mesenchymal stem cells: human platelet-derived factors regulate multiple biological processes
Onkologie. 29(S3):232-232.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY.
[Poster]
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk D
Impact of either human platelet lysate-versus fetal bovine serum-derived factors on mesenchymal stem cell gene expression Abstract book p46
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006.
[Poster]
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic V; Strunk, D
Human platelet lysate supports cord blood derived mesenchymal stem cells (poster & abstract)
EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells; OKT 6-8, 2006; Mandelieu, France. 2006.
[Poster]
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk, D
A humanized system to propagate cord blood derived mesenchymal stem cells for clinical applications.
1st Meeting of the Center for Medical Research ; OCT 24; Graz. 2006.
[Oral Communication]
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk, D
A humanized system to propagate cord blood-derived mesenchymal stem cells for clinical applications
ONKOLOGIE. 29(S3):28-28.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; NOV 4-8; Leipzig, GERMANY.
[Oral Communication]
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk, D
A humanized system to propagate cord blood derived mesenchymal stem cells for clinical application.
European Surgery. European Surgery2006; 38(S211):12-12.-Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21, 2006; Hof - Salzburg, AUSTRIA.
[Oral Communication]
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk D
Human platelet lysate for propagation of cord blood derived mesenchymal stem cells Abstract book p 50
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006.
[Poster]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
EndoCult or T-Occult? Immune cell interactions control endothelial function
1st Minisymposium on Gene Expression and Microarray Technology; MAY 11, 2006; Graz, AUSTRIA. 2006.
[Oral Communication]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells support vascular regeneration: unraveling the nature of CFU-EC.
Onkologie. 29(3):28-28.-Deutsche Gesellschaft für Hämatologie und Onkologie, DGHO ; Nov 4-8, 2006; Leipzig, Germany.
[Oral Communication]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Vascular regeneration and immune cell support unraveling the nature of CFU-EC.
1st Meeting of the Center for Medical Research ; OCT 24; Graz. 2006.
[Oral Communication]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Towards the standardization of GMP-compliant generation of mesenchymal stem cells.
DGTI, Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie; Sept 19-22, 2006; Frankfurt, Germany. 2006.
[Oral Communication]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
Immune cells mimic endothelial progenitor colonies.
BLOOD. 2006; 108(11): 513A-513A.
Doi: 10.1182/blood.V108.11.1811.1811
[Poster]
Web of Science
FullText
FullText_MUG
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk D
Immune cells support vascular regeneration- unraveling the nature of CFU-EC.
European Surgery. European Surgery2006; 38(211):4-4.-20th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21, 2006; Salzburg, Austria.
[Oral Communication]
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk D
Immune Cells and Vascular Regeneration - Unraveling the Nature of CFU-EC Abstract book p45
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006.
[Poster]
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Preclinical expansion of mesenchymal stem cells is efficiently supported by human platelet lysate (poster & abstract)
EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells; OKT 6-8, 2006; Mandelieu, France. 2006.
[Poster]
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Mesenchymal stem cell therapy: human platelet lysates support efficient preclinical expansion
European Surgery. 38(S211):13-13.-Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21; Hof - Salzburg, AUSTRIA.
[Oral Communication]
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
BLOOD. 2006; 108(11): 1042A-1042A.
Doi: 10.1182/blood.V108.11.3649.3649
[Poster]
Web of Science
FullText
FullText_MUG
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Mesenchymal stem cell therapy: human platelet lysate supports efficient preclinical expansion
Onkologie. Onkologie2006; 29(S3):232-232.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY.
[Poster]
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
Preclinical expansion of mesenchymal stem cells is efficiently supported by human platelet lysate.
1st Meeting of the Center for Medical Research ; OCT 24; Graz. 2006.
[Oral Communication]
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk D
Human platelet lysates promote efficient preclinical expansion for human mesenchymal stem cell therapy Abstract Book p51
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006.
[Poster]